Roman DBDR Acquisition Corp. II - 8-K Summary
Business Context and Reporting Period
Roman DBDR Acquisition Corp. II, a Cayman Islands-based emerging growth company, filed this Current Report on Form 8-K on December 16, 2024. The filing documents the consummation of the Company's initial public offering (IPO) and a concurrent private placement of warrants.
Key Financial Metrics
- Gross Proceeds from IPO: $200,000,000 from the sale of 20,000,000 Units at $10.00 per Unit.
- Gross Proceeds from Private Placement: $7,385,000 from the sale of 7,385,000 Private Placement Warrants at $1.00 per warrant.
- Total Funds Deposited in Trust: $201,000,000 ($10.05 per Unit).
- Over-Allotment Option: Underwriters hold a 45-day option to purchase up to 3,000,000 additional Units.
- Warrant Exercise Price: $11.50 per share for public warrants.
The filing does not provide data on revenue, operating profit, cash flow from operations, or debt levels, as the Company is a special purpose acquisition company (SPAC) in its pre-business combination stage. Liquidity is primarily represented by the funds held in the trust account.
Material Changes
This filing represents the Company's transition from a private entity to a publicly traded company on The Nasdaq Stock Market LLC. There is no prior comparable period for financial performance as this is the initial capitalization event. The Company now has three classes of securities trading: Units (DRDBU), Class A ordinary shares (DRDB), and Warrants (DRDBW).
Outlook and Risks
The Company intends to use the proceeds from the IPO and private placement to consummate a business combination with one or more target businesses. The filing notes that an audited balance sheet as of December 16, 2024, is included as Exhibit 99.1. No specific guidance regarding the timeline for a business combination or specific target sectors is provided in this text. Standard risks associated with SPACs, including the risk of failing to complete a business combination within the required timeframe, apply.
Investor Verification Checklist
- Verify the status of the 45-day over-allotment option and whether underwriters have exercised it.
- Review the audited balance sheet (Exhibit 99.1) to confirm the exact cash balance and any initial working capital outside the trust.
- Confirm the terms of the Private Placement Warrants, specifically regarding redemption rights and transferability compared to public warrants.
- Monitor subsequent filings for the identification of a target business and the proposed business combination agreement.